The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 13, 2026 in Phreesia, Inc. Lawsuit - PHR

The Gross Law Firm issues the following notice to shareholders of Phreesia, Inc. (NYSE: PHR). Shareholders who purchased shares of PHR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD: May 8, 2025 to March 30, 2026

ALLEGATIONS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Phreesia’s slowing demand and reduced visibility in key revenue streams, notably, the weakened pharmaceutical marketing commitments in its Network Solutions segment. On March 30, 2026, Phreesia announced significantly reduced revenue growth projections for fiscal year 2027 guidance. The Company attributed the shortfall against its prior guidance to a combination of macroeconomic factors including “worsening visibility” and weaker pharmaceutical marketing commitments within its Network Solutions segment. Following this news, the price of Phreesia’s common stock declined from a closing market price of $11.41 per share on March 30, 2025, to $8.38 per share on March 31, 2026, a decline of about 27%.

DEADLINE: July 13, 2026 Shareholders should not delay in registering for this class action.